Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting

被引:5
|
作者
Giorda, C. B. [1 ]
Mulas, M. F. [2 ]
Manicardi, V. [3 ]
Suraci, C. [4 ]
Guida, P. [5 ]
Marafetti, L. [1 ]
Nada, E. [6 ]
Gentile, S. [7 ]
机构
[1] ASL, Metab & Diabet Unit, Turin 5, Italy
[2] Metab & Diabet Unit, Oristano, Italy
[3] Montecchio Hosp, Montecchio Emilia, Italy
[4] Pertini Hosp, Metab & Diabet Unit, Rome, Italy
[5] Univ Bari, Emergency & Organ Transplantat Dept, Cardiol Unit, Bari, Italy
[6] Chaira Med Assoc, Chieri, Italy
[7] Univ Naples Federico II, Naples, Italy
关键词
HbA1c normalization; Type 2 diabetes treatment; Organizational factors; Clinical factors; CARE; COMPLICATIONS; INTERVENTION; ONSET; TEAM;
D O I
10.1007/s00592-012-0431-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The time to achieve good metabolic control after diagnosis is essential for type 2 diabetes patients because it can influence long-term prognosis. This study aimed to elucidate the predictive role of several clinical and organization factors in normalizing metabolism within 6 months. A multi-centered, retrospective, observational study on 960 patients, with diabetes duration of 12 months or less, consecutively seen in 123 Italian clinics, was undertaken. Information about clinic's organization, along with data abstracted from medical records at enrollment (first visit) and after 6 months (follow-up visit), was collected. At 6 months, HbA1c dropped by -3.1 +/- A 2.2 points in those who achieved HbA1c < 7 % (responders), whereas in non-responders (HbA1c a parts per thousand yen7 %), the mean reduction was -1.8 +/- A 1.9. The intervention markedly reduced lipids, blood pressure, BMI, and waist circumference, especially in responders. The presence of a diabetes team correlated with a likelihood of HbA1c normalization (OR 1.94, 1.17-3.22). By contrast, indicators of advanced disease such as previous retinopathy (0.53, 0.29-0.98), use of secretagogues (0.40, 0.25-0.64), high levels of HbA1c at first visit and related insulin use emerged as adverse factors. Early detection of diabetes, along with human resources and organization, was found to play a crucial role in rapidly attaining good metabolic control.
引用
收藏
页码:81 / 87
页数:7
相关论文
共 50 条
  • [1] Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting
    C. B. Giorda
    M. F. Mulas
    V. Manicardi
    C. Suraci
    P. Guida
    L. Marafetti
    E. Nada
    S. Gentile
    Acta Diabetologica, 2013, 50 : 81 - 87
  • [2] HbA1c Trajectory and Its Associated Factors in Patients with Type 2 Diabetes
    Yu, Tzu-Yun
    Li, Tsai-Chung
    Lin, Cheng-Chieh
    DIABETES, 2016, 65 : A607 - A607
  • [3] Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels
    Zhang, Jin-Ping
    Wang, Na
    Xing, Xiao-Yan
    Yang, Zhao-Jun
    Wang, Xin
    Yang, Wen-Ying
    JOURNAL OF DIABETES, 2016, 8 (04) : 559 - 567
  • [4] FPG and HbA1c are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
    Kim, JI
    Stevens, RJ
    Holman, RR
    DIABETOLOGIA, 2005, 48 : A33 - A33
  • [5] The age at diagnosis predicts change in HbA1c over time in patients with newly diagnosed type 2 diabetes
    Elgzyri, T.
    Almgren, P.
    Eliasson, M.
    Parikh, H.
    Lindholm, E.
    Eriksson, K-F.
    Groop, L.
    DIABETOLOGIA, 2006, 49 : 46 - 46
  • [6] Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes
    Li, Sheyu
    Nemeth, Imola
    Donnelly, Louise
    Hapca, Simona
    Zhou, Kaixin
    Pearson, Ewan R.
    DIABETES CARE, 2020, 43 (02) : 426 - 432
  • [7] Visit-to-visit HbA1c variability is associated with cardiovascular diseases and microvascular complications in patients with newly diagnosed type 2 diabetes
    Li, S.
    Nemeth, I.
    Donnelly, L.
    Zhou, K.
    Pearson, E. R.
    DIABETOLOGIA, 2019, 62 : S572 - S573
  • [8] Distinct trajectories in HbA1c are associated with different all-cause mortality and morbidity in newly diagnosed patients with type 2 diabetes
    Hemo, Beatriz
    Geva, Dikla
    Shahar, Danit R.
    Golan, Rachel
    Heymann, Anthony D.
    PRIMARY CARE DIABETES, 2020, 14 (05) : 413 - 419
  • [9] THE CHANGES OF HBA1C VALUES AND RELATIONSHIP BETWEEN HBA1C VARIABILITY AND DIABETIC NEPHROPATHY IN NEWLY DIAGNOSED TYPE 2 DIABETIC PATIENTS
    Jo, A.
    Cho, M.
    Lee, K. J.
    Kim, M. -K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S125 - S125
  • [10] Trends in HbA1c and other biochemical outcomes of individuals with newly diagnosed type 1 diabetes
    A. O’Carroll-Lolait
    A. Urwin
    I. Doughty
    J. Schofield
    H Thabit
    L. Leelarathna
    Irish Journal of Medical Science (1971 -), 2021, 190 : 999 - 1004